Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News Cancer Research UK appoints new Trustee from the University of Birmingham Cancer Research UK has announced the appointment of Professor Pamela Kearns, Director of the Institute of Cancer and Genomic Sciences, as a Trustee and Member.
News Cancer researchers show that different mutations in the same gene can cause different types of cancer.
News Birmingham scientists 're-train' immune system to prevent attack of healthy cells in new UK study into autoimmune diseases
Posted 19 February 2021 Research paves way for rapid non-invasive diagnosis of some childhood brain tumours A study led by the University of Birmingham has found combining advanced imaging and artificial intelligence techniques can accurately classify the characteristics of common types of childhood brain tumours.
Posted 29 January 2021 Birmingham Brief: What happened to cancer while COVID-19 took the front seat? Professor Pam Kearns, Director of the Institute of Cancer and Genomic Sciences, writes an opinion piece on how COVID-19 has replaced cancer as 'the big C'.
Posted 25 January 2021 Better post-surgical care would boost cancer survival chances Patients' chances of survival after cancer surgery is strongly linked with the standard of post-operation hospital care, a major international study suggests.